维普中文期刊产品整合服务
34篇 您的检索式:作者名="Pintzas"
    题名 作者 年代 出处 被引量
1Epithelial–mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic显示文摘Angeliki Voulgari Alexander Pintzas 2009BBA - Reviews on Cancer2009,,2:2
2Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers, and strategies to overcome drug re- sistance in the clinic 显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
3Epithelial-mesenchymal transition in cancer metastasis: mechanisms,markers and strategies to overcome drug resistance in the clinic 显示文摘Voulqari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
4Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
5Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
6Oncogenic RAS alters the global and gene-specific histone modification pattern during epithelial–mesenchymal transition in colorectal carcinoma cells显示文摘Ignacio Mazón Peláez Margarita Kalogeropoulou Angelo Ferraro Angeliki Voulgari Tibor Pankotai Imre Boros Alexander Pintzas 2010International Journal of Biochemistry and Cell Biology2010,,6:1
7Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic 显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
8Epithelial - mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resist- ance in the clinic 显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
9Molecular mecha nisms involved in CD43-mediated apoptosis of TF-lcells 显示文摘Cermak L Simovd S Pintzas A 2002J Bioll Chem2002,277,10:1
10Epithelial - mesenehymal transition in cancer metastasis: mechanisms, markers and strategies to over- come dmgresistance in the clinic 显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
11Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
12Epithelial-mesenchymal transition in cancer me- tastasis :mechanisms, markers and strategies to overcome drug resistance in the clinic显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
13The TRAIL of oncogenes to apop-tosis显示文摘Oikonomou E Pintzas A 2013Biofactors2013,39,4:1
14EZH2 regulates cofilin activity and co- lon cancer cell migration by targeting ITGA2 gene 显示文摘Ferraro A Boni T Pintzas A 2014PLoS One2014,9,15:1
15Epithelial-mesenchymal transition in cancer metastasis : mechanisms, markers and strategies to overcome drug resistance in the clinic显示文摘Voulgari A Pintzas A 2009Biochim Bio- phys Acta2009,1796,2:1
16Epithelial-mesenehymal transition in cancer metastasis:Mechanisms markers and strategies to overcome drug resistance in the clinic 显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
17Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells显示文摘Psahoulia FH Moumtzi S Roberts ML Sasazuki T Shirasawa S Pintzas A 2007Carcinogenesis2007,28,5:1
18Epithelial-mesenchymal transition in cancer metastasis:mechanisms,markers and strategies to overcome drug resistance in the clinic显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
19Cancer genetics of sporadic colorectal eancer:BRAF and PI3KCA mutations, their impact on signaling and novel targeted therapies显示文摘Oikonomou E Pintzas A 2006Anticancer Res2006,26,2:1
20Epithelial-mesenchymal transition in cancer metastasis:mechanisms,markers and strategies to overcome drug resistance in the clinic显示文摘Voulgari A Pintzas A 2009Biochim Biophys Acta2009,1796,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费